Michael Spinner, Md

This study is testing a combination of four drugs (pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin) for adults whose classic Hodgkin lymphoma has returned or not responded to initial treatment. It aims to see if this treatment can achieve a deep remission, meas…